References
- Akacha, M., Bretz, F., and Ruberg, S. (2017), “Estimands in Clinical Trials—Broadening the Perspective,” Statistics in Medicine, 36, 5–19. DOI: https://doi.org/10.1002/sim.7033.
- Angrist, J. D., Imbens, G. W., and Rubin, D. B. (1996), “Identification of Causal Effects Using Instrumental Variables,” Journal of the American Statistical Association, 91, 444–455. DOI: https://doi.org/10.1080/01621459.1996.10476902.
- Barnard, J., and Rubin, D. B. (1999), “Miscellanea. Small-Sample Degrees of Freedom With Multiple Imputation,” Biometrika, 86, 948–955.
- Bornkamp, B., and Bermann, G. (2020), “Estimating the Treatment Effect in a Subgroup Defined by an Early Post-Baseline Biomarker Measurement in Randomized Clinical Trials With Time-to-Event Endpoint,” Statistics in Biopharmaceutical Research, 12, 19–28. DOI: https://doi.org/10.1080/19466315.2019.1575280.
- Chiba, Y., and VanderWeele, T. J. (2011), “A Simple Method for Principal Strata Effects When the Outcome Has Been Truncated Due to Death,” American Journal of Epidemiology, 173, 745–751. DOI: https://doi.org/10.1093/aje/kwq418.
- Ding, P., Geng, Z., Yan, W., and Zhou, X.-H. (2011), “Identifiability and Estimation of Causal Effects by Principal Stratification With Outcomes Truncated by Death,” Journal of the American Statistical Association, 106, 1578–1591. DOI: https://doi.org/10.1198/jasa.2011.tm10265.
- Feller, A., Mealli, F., and Miratrix, L. (2016), “Principal Score Methods: Assumptions and Extensions,” arXiv no. 1606.02682.
- Frangakis, C. E., and Rubin, D. B. (2002), “Principal Stratification in Causal Inference,” Biometrics, 58, 21–29. DOI: https://doi.org/10.1111/j.0006-341x.2002.00021.x.
- Hayden, D., Pauler, D. K., and Schoenfeld, D. (2005), “An Estimator for Treatment Comparisons Among Survivors in Randomized Trials,” Biometrics, 61, 305–310. DOI: https://doi.org/10.1111/j.0006-341X.2005.030227.x.
- ICH E9 (R1) (2019), “Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials,” Technical Report, EMA/CHMP/ICH/436221/201, Step 4 (Final Version adopted on 20 Nov 2019).
- Imai, K. (2008), “Sharp Bounds on the Causal Effects in Randomized Experiments With ‘Truncation-by-Death’,” Statistics & Probability Letters, 78, 144–149.
- Imbens, G. W., and Rubin, D. B. (1997), “Bayesian Inference for Causal Effects in Randomized Experiments With Noncompliance,” The Annals of Statistics, 25, 305–327. DOI: https://doi.org/10.1214/aos/1034276631.
- Jin, H., and Rubin, D. B. (2008), “Principal Stratification for Causal Inference With Extended Partial Compliance,” Journal of the American Statistical Association, 103, 101–111. DOI: https://doi.org/10.1198/016214507000000347.
- Jo, B., and Stuart, E. A. (2009), “On the Use of Propensity Scores in Principal Causal Effect Estimation,” Statistics in Medicine, 28, 2857–2875. DOI: https://doi.org/10.1002/sim.3669.
- Lou, Y., Jones, M. P., and Sun, W. (2019), “Estimation of Causal Effects in Clinical Endpoint Bioequivalence Studies in the Presence of Intercurrent Events: Noncompliance and Missing Data,” Journal of Biopharmaceutical Statistics, 29, 151–173. DOI: https://doi.org/10.1080/10543406.2018.1489408.
- Louizos, C., Shalit, U., Mooij, J. M., Sontag, D., Zemel, R., and Welling, M. (2017), “Causal Effect Inference With Deep Latent-Variable Models,” in Advances in Neural Information Processing Systems, pp. 6446–6456.
- Lu, X., Mehrotra, D., and Shepherd, B. (2013), “Rank-Based Principal Stratum Sensitivity Analyses,” Statistics in Medicine, 32, 4526–4539. DOI: https://doi.org/10.1002/sim.5849.
- Luo, J., Ruberg, S. J., and Qu, Y. (2021), “Estimating the Treatment Effect for Adherers Using Multiple Imputation,” arXiv no. 2102.03499.
- Magnusson, B. P., Schmidli, H., Rouyrre, N., and Scharfstein, D. O. (2018), “Bayesian Inference for a Principal Stratum Estimand to Assess the Treatment Effect in a Subgroup Characterized by Post-Randomization Events,” arXiv no. 1809.03741.
- Mehrotra, D. V., Li, X., and Gilbert, P. B. (2006), “A Comparison of Eight Methods for the Dual-Endpoint Evaluation of Efficacy in a Proof-of-Concept HIV Vaccine Trial,” Biometrics, 62, 893–900. DOI: https://doi.org/10.1111/j.1541-0420.2005.00516.x.
- Permutt, T. (2016), “A Taxonomy of Estimands for Regulatory Clinical Trials With Discontinuations,” Statistics in Medicine, 35, 2865–2875. DOI: https://doi.org/10.1002/sim.6841.
- Permutt, T. (2018), “Effects in Adherent Subjects,” Statistics in Biopharmaceutical Research, 10, 233–235.
- Qu, Y., Fu, H., Luo, J., and Ruberg, S. J. (2020), “A General Framework for Treatment Effect Estimators Considering Patient Adherence,” Statistics in Biopharmaceutical Research, 12, 1–18. DOI: https://doi.org/10.1080/19466315.2019.1700157.
- Qu, Y., Luo, J., and Ruberg, S. J. (2021), “Implementation of Tripartite Estimands Using Adherence Causal Estimators Under the Causal Inference Framework,” Pharmaceutical Statistics, 20, 55–67. DOI: https://doi.org/10.1002/pst.2054.
- Shepherd, B. E., Gilbert, P. B., and Dupont, C. T. (2011), “Sensitivity Analyses Comparing Time-to-Event Outcomes Only Existing in a Subset Selected Postrandomization and Relaxing Monotonicity,” Biometrics, 67, 1100–1110. DOI: https://doi.org/10.1111/j.1541-0420.2010.01508.x.
- Small, D., and Tan, Z. (2007), “A Stochastic Monotonicity Assumption for the Instrumental Variables Method,” Unpublished working paper.
- VanderWeele, T. J. (2011), “Principal Stratification—Uses and Limitations,” The International Journal of Biostatistics, 7, 1–14. DOI: https://doi.org/10.2202/1557-4679.1329.
- Zhang, J. L., and Rubin, D. B. (2003), “Estimation of Causal Effects via Principal Stratification When Some Outcomes Are Truncated by ‘Death’,” Journal of Educational and Behavioral Statistics, 28, 353–368. DOI: https://doi.org/10.3102/10769986028004353.